{
    "eid": "2-s2.0-85129600697",
    "title": "Anti-Protease Activity Deficient Secretory Leukocyte Protease Inhibitor (SLPI) Exerts Cardioprotective Effect against Myocardial Ischaemia/Reperfusion",
    "cover-date": "2022-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (miscellaneous)",
            "@code": "2701",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Biochemistry, Genetics and Molecular Biology (all)",
            "@code": "1300",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "antiprotease deficient",
        "cardioprotection",
        "myocardial ischaemia/reperfusion injury",
        "protease activity",
        "SLPI"
    ],
    "authors": [
        "Podsawee Mongkolpathumrat",
        "Anusak Kijtawornrat",
        "Eukote Suwan",
        "Sasimanas Unajak",
        "Aussara Panya",
        "Tonapha Pusadee",
        "Sarawut Kumphune"
    ],
    "citedby-count": 2,
    "ref-count": 45,
    "ref-list": [
        "Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response",
        "Secretory leukocyte peptidase inhibitor expression and apoptosis effect in oral leukoplakia and oral squamous cell carcinoma",
        "Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor",
        "Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I",
        "Inhibition of NF-\u03baB Activation and Augmentation of I\u03baB\u03b2.; by Secretory Leukocyte Protease Inhibitor during Lung Inflammation",
        "The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity",
        "Secretory leukocyte protease inhibitor is a proliferation and survival factor for pancreatic cancer cells",
        "Overexpression and pre-treatment of recombinant human Secretory Leukocyte Protease Inhibitor (rhSLPI) reduces an in vitro ischemia/reperfusion injury in rat cardiac myoblast (H9c2) cell",
        "The Recombinant Human Secretory Leukocyte Protease Inhibitor (SLPI) protects cardiac fibroblasts injury against an in vitro ischemia/reperfusion injury",
        "An in vitro endothelial cell protective effect of secretory leukocyte protease inhibitor against simulated ischaemia/reperfusion injury",
        "Endothelial-Cell-Derived Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiomyocytes against Ischemia/Reperfusion Injury",
        "Recombinant human secretory leukocyte protease inhibitor ameliorated vessel preservation in experimentally isolated rat arteries",
        "The cardioprotective effects of secretory leukocyte protease inhibitor against myocardial ischemia/reperfusion injury",
        "Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury",
        "Protease inhibitor side effects take people by surprise",
        "Protease inhibitors\u2019 metabolic side effects: Cholesterol, triglycerides, blood sugar, and \u201cCrix belly.\u201d Interview with Lisa Capaldini, M.D. Interview by John S. James",
        "Location of the protease-inhibitory region of secretory leukocyte protease inhibitor",
        "Heparin interferes with the inhibition of neutrophil elastase by its physiological inhibitors",
        "The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps",
        "Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function",
        "miR-98 protects endothelial cells against hypoxia/reoxygenation induced-apoptosis by targeting caspase-3",
        "Role of various proteases in cardiac remodeling and progression of heart failure",
        "Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications",
        "Neutrophils as regulators of cardiovascular inflammation",
        "Dual inhibition of cathepsin G and chymase reduces myocyte death and improves cardiac remodeling after myocardial ischemia reperfusion injury",
        "Role of cellular proteinases in acute myocardial infarction I. proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin, pepstatin and chymostatin administered in vivo",
        "Proteolytic enzymes activities in patients after myocardial infarction correlate with serum concentration of TGF-beta",
        "Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats",
        "Protease inhibitors and cardiovascular disease: Analysis of the Los Angeles County adult spectrum of disease cohort",
        "Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure",
        "Impact of Treatment With Protease Inhibitors on Aortic Stiffness in Adult Patients With Human Immunodeficiency Virus Infection",
        "Cardiovascular disease and use of contemporary protease inhibitors: The D:A:D international prospective multicohort study",
        "Membrane-anchored serine proteases in health and disease",
        "Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding",
        "Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection",
        "Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma",
        "A kinase-independent function of AKT promotes cancer cell survival",
        "The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane",
        "Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt\u2013Mdm2\u2013p53 pathway",
        "Peptidyl Activity-Based Probes for Imaging Serine Proteases",
        "MEROPS: The protease database",
        "Serine proteases",
        "The elimination of secretory leukocyte protease inhibitor (SLPI) after intravenous injection in dog and man",
        "Cementoin-SLPI fusion protein binds to human monocytes and epithelial cells and shows higher biological activity than SLPI",
        "Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases"
    ],
    "affiliation": [
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pitsanulok",
            "@id": "60022498",
            "affilname": "Naresuan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022498",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60021944",
            "affilname": "Kasetsart University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021944",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chiang Mai University",
        "Thailand Research Fund"
    ]
}